ÂÜÀòÂÒÂ×

Will Andrews, MD, is a biopharmaceutical executive with a focus on clinical development and medical affairs, particularly in rare diseases. Currently serving as the Chief Medical Officer at Catalyst Pharmaceuticals, Will has extensive experience in launching multiple therapeutic products and leading clinical initiatives across various global markets. Previously, Will held executive roles at companies such as Flexion Therapeutics and Akcea Therapeutics, where they directed clinical strategies and managed regulatory affairs that led to significant product approvals. Will’s early career included practicing internal medicine and contributing as faculty at Harvard Medical School.